The Treatment of Elderly Patients With Lymphoma
Andre Goy, MD, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses the treatment of elderly patients with lymphoma.
Clinical Pearls
Andre Goy, MD, chairman, director, and chief of the Lymphoma Division at the John Theurer Cancer Center, discusses the treatment of elderly patients with lymphoma.
- Data from the GELA trial were impressive: Benefit was seen regardless of age with the R-CHOP combination
- Elderly patients typically have more aggressive and higher risk disease
- The standard of care is R-CHOP-21, though patients in good condition with high-risk disease can tolerate R-EPOCH
- Frail patients should be treated with mini-CHOP
- The incidence of large cell lymphoma in the elderly has increased 500% in the last 10 years, creating a need for better therapeutic options
Recent Videos
Related Content
Examining the Non-Hodgkin Lymphoma Treatment Paradigm
July 15th 2022Podcast
In season 3, episode 6 of Targeted Talks, Yazan Samhouri, MD, discusses the exciting new agents for the treatment of non-Hodgkin lymphoma, the clinical trials that support their use, and hopes for the future of treatment.
Listen
